No abstract

No abstract

No abstract

Phytocompounds in an aqueous methanol (70% MeOH) leaf extract of Searsia lancea were separated using liquid-liquid partitioning techniques and gravity-assisted column chromatography. The resultant fractions were screened for antibacterial properties (minimum inhibitory concentration, MIC) against four bacterial strains (Enterococcus faecalis, Klebsiella pneumoniae, Neisseria gonorrhoeae and Staphylococcus aureus). Bioactive fractions were purified using preparative thin layer chromatography (TLC) and subjected to further antibacterial screening. Phytocompounds in antibacterial sub-fractions were characterized and quantified using Gas Chromatography-Mass Spectrometry (GC-MS). An ethyl acetate sub-fraction purified from the aqueous methanol extracts of the leaves demonstrated potent antibacterial properties (MIC range: 31-61 µg/ml against E. faecalis and S. aureus). Based on GC-MS analysis, 81.5% of the sub-fraction consisted of broad-spectrum antibacterial compounds namely tetracosanol (43.98%) and nonadecanol (37.5%). Current research findings support the traditional use of S. lancea leaves to manage gastro-intestinal disorders and gonorrhoea.

Microalgae are potential plant biostimulants and biocontrol agents. A major hurdle towards their commercialization is the production of large volumes of biomass at the correct time of year. Secondary metabolites are unstable and the “shelf-life” of bioactive microalgal biomass needs to be investigated. The aim of the study was to investigate the effects of storage conditions on freeze-dried microalgae to determine how long the biomass retained its growth promoting and bioactive properties under various temperature and light conditions. Chlorella vulgaris biomass was stored in the dark at − 70 °C, 10 °C, and 25 °C and in the light at 25 °C. Samples were tested every 3–4 months for 15 months. Storage time significantly influenced the rate of change in the bioactivity in the C. vulgaris biomass with storage temperature also having some effect. Rooting activity decreased in the mungbean rooting assay over time up to 12 months and then increased slightly. Antimicrobial activity increased against Staphylococcus aureus and Escherichia coli for up to 12 months and then declined. Antioxidant activity measured in the DPPH assay remained relatively stable for up to 12 months and then significantly decreased with longer storage. The change in bioactivity over time was attributed to the gradual breakdown of the rigid cell wall of C. vulgaris , thereby improving extraction efficiency but exposing the secondary metabolites to oxygen, thus quickening their degradation. Biomass produced for commercial purposes requires preliminary validation as the results of the present study showed that bioactive compounds are susceptible to degradation over time. Supplementary Information The online version contains supplementary material available at 10.1007/s10811-021-02596-9.

Protea caffra is used as a diarrhoeal remedy in South African herbal medicine, however, its pharmacological properties remain largely unknown. In the present study, extracts from different Protea caffra organs were screened against drug-sensitive and -resistant diarrhoeagenic pathogens using the microdilution assay (minimum inhibitory concentration, MIC). Twig extracts (70% methanol, MeOH) of the plant were purified and the resultant fractions screened for antibacterial properties (MIC). The chemical profiles of the fractions were determined by Gas Chromatography-Mass Spectrometry (GC-MS), while ultra-high-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) was used to quantify the phenolic acids in the plant. The mutagenic properties of bioactive extracts were assessed using the Ames test. The extracts demonstrated weak-moderate antibacterial properties (MIC: 0.3–0.6 mg/mL). A cold ethyl acetate fraction of MeOH twig extract exhibited significant antibacterial properties (MIC = 0.078 mg/mL) against Enterococcus faecalis. The presence of antibacterial compounds (1-adamantane carboxylic acid, heptacosanol, levoglucosan, nonadecanol) in the plant was putatively confirmed based on GC-MS analysis. Furthermore, UHPLC-MS/MS analysis revealed varying concentrations of phenolic acids (0.08–374.55 µg/g DW). Based on the Ames test, the extracts were non-mutagenic thereby suggesting their safety. To a certain degree, the current study supports the traditional use of Protea caffra to manage diarrhoea among local communities in South Africa.

No abstract

Background: Pseudomonas aeruginosa is amongst the three high-ranking pathogens on the World Health Organization’s global priority list of antibiotic-resistant bacteria. The list highlights research priorities in drug discovery and development.Aim: This study aimed to provide a detailed account of efforts by researchers to find anti-P. aeruginosa compounds from South African medicinal plant species during the period 2000–2020.Method: Various online research and journal databases were used to obtain information relating to South African medicinal plants and P. aeruginosa.Results: During the study period (2000–2020), only 31 studies reported on the antibacterial properties of South African medicinal plants against the pathogen. Given that P. aeruginosa is a serious cause of morbidity and mortality worldwide, it was interesting to note that none of the published reports were dedicated solely to the pathogen. Furthermore, only one study included the antibiotic-resistant mutants of the pathogen as a test organism. Over 150 plant species belonging to 78 families were screened against the bacterium. Barringtonia racemosa, Croton megalobotrys, Erythrina caffra, Leucosidea sericea, Maesa lanceolata, Morella serrata and Trichilia emetica exhibited potent anti-P. aeruginosa properties (minimum inhibitory concentration [MIC] ˂ 0.1 mg/mL). Plumbagin, a compound isolated from the leaves of Aristea ecklonii demonstrated promising activities (MIC = 0.008 mg/mL) against the bacterium. Essential oils extracted from some plants demonstrated noteworthy antibacterial synergistic effects (fractional inhibitory concentration index [FICI] ˂ 0.5) when used in pairwise combinations with conventional antibiotics.Conclusion: Overall, empirical evidence presented in the scantly available literature suggests that novel anti-P. aeruginosa agents could be developed from South African herbal extracts.